Loading insider details...
Beta
Latest Form 4 (Sep 23, 2025): Grant/Award of 825,000 CTOR shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 23, 2025 | CITIUS ONCOLOGY, INC. (CTOR) | Grant/Award | 825,000 | n/a |
| Dec 16, 2024 | CITIUS ONCOLOGY, INC. (CTOR) | Grant/Award | 400,000 | n/a |
| Nov 12, 2024 | Citius Pharmaceuticals, Inc. (CTXR) | Grant/Award | 300,000 | n/a |
| Aug 14, 2024 | CITIUS ONCOLOGY, INC. (CTOR) | Grant/Award | 466,667 | n/a |
| Oct 12, 2023 | Citius Pharmaceuticals, Inc. (CTXR) | Grant/Award | 300,000 | n/a |
| Oct 6, 2022 | Citius Pharmaceuticals, Inc. (CTXR) | Grant/Award | 300,000 | n/a |
| Oct 13, 2021 | Citius Pharmaceuticals, Inc. (CTXR) | Grant/Award | 300,000 | n/a |
| Jul 15, 2020 | Citius Pharmaceuticals, Inc. (CTXR) | Grant/Award | 500,000 | n/a |